<--- Back to Details
First PageDocument Content
Medicine / Antiviral drug / Peginterferon alfa-2a / Microbiology / HIV/AIDS / Hepacivac / Viral hepatitis / Hepatitis / Health / Hepatitis C
Date: 2014-09-18 02:00:17
Medicine
Antiviral drug
Peginterferon alfa-2a
Microbiology
HIV/AIDS
Hepacivac
Viral hepatitis
Hepatitis
Health
Hepatitis C

hepatitis C BASICS New Alan Franciscus

Add to Reading List

Source URL: www.hcvadvocate.org

Download Document from Source Website

File Size: 283,29 KB

Share Document on Facebook

Similar Documents

Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

DocID: 1vngt - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

DocID: 1vjI2 - View Document

APASL and CEVHAP Partnership: a Hepatitis-Free World November

DocID: 1vgwC - View Document

California Institute of Technology Hepatitis B Vaccination Offer Form Occupational Exposure to Bloodborne Pathogens Please complete this form if you may come in contact with human blood or other potentially infectious hu

DocID: 1vf93 - View Document